{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259073046", "close" : "1259096446", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
ap

Medicines Co. sues generic rivals over Angiomax

Medicines Co. sues Teva and APP Pharma over patents supporting anti-clotting drug Angiomax

  • On 5:45 pm EDT, Thursday October 8, 2009

PARSIPPANY, N.J. (AP) -- The Medicines Co. said Thursday it filed three patent infringment lawsuits against drugmakers who are hoping to sell a generic version of its anti-clotting agent Angiomax.

The company sued Teva Parenteral Medicines, Pliva Hrvatska and APP Pharmaceuticals, saying each one violated a patent supporting Angiomax. That patent was awarded to Medicines Co. on Sept. 1. Each company has filed for Food and Drug Administration approval of a generic form of Angiomax.

Teva Parenteral Medicines and Pliva are both units of Teva Pharmaceuticals Industries Ltd., the world's largest maker of generic drugs. APP Pharmaceuticals is part of Fresenius Kabi Pharmaceuticals Holding Inc.

Medicines Co. stock was unchanged at $10.11 in aftermarket trading.

Related Headlines

Related Blog Headlines

Top Stories

Related Message Boards

Sponsored Links

Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.